InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,985.38
(
0.02%
)
US TECH 100
20,504.80
(
0.07%
)
Dow Jones
43,958.19
(
0.00%
)
Brent Oil
72.55
(
0.95%
)
Bitcoin
91,249.48
(
0.76%
)
Post# of 253594
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: mcbio post# 120806

Tuesday, 05/31/2011 11:28:57 PM

Tuesday, May 31, 2011 11:28:57 PM

Post# of 253594
I don't follow the company, but based on the abstract I assumed they were both their vaccines:

We examined patients from our E75 and vaccine X clinical trials.



If they aren't both RXII owned vaccines, then at least they seem to be similar:

E75 (HER2: 369-377) and another vaccine (X) are HLA-A2/3+-restricted peptides capable of stimulating CD8+ cytotoxic T cells with anti-HER2 tumor activity.



This company used to be a RNAi company, but I guess they have transformed themselves.

Peter


Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up